Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
308
Total raised
£4.1B
disclosed amounts
This month
£27.8M
raised so far
The University of Edinburgh spin-out has secured backing to fund its first human trials.
"The BioCollector is a disruptive technology which will be transformational for liquid biopsy testing. We are confident that this platform technology can make a significant impact in this important area and, ultimately, enable cancers to be detected more quickly and accurately, enabling patients to receive precision cancer treatment as early as possible."
The funding was provided by o2h Ventures to back the University of Sussex spin out.
"We are delighted to be working with the University of Sussex and the founders to launch and grow Stingray Bio. We have been following the science for several years and we are now excited to support the commercialisation of the founder's research to develop new drugs for cancer."
The company has received funding from Innovate UK to apply its artificial intelligence platform to glioblastoma multiforme research.
"The goal of GlamAI is to break new ground in applications of AI for drug discovery and accelerate the path to personalized medicine in labs around the world. We are very proud of the progress we’ve made so far to validate our approach. Through our partnership with King’s College London, GlamAI will collaborate with experts in glioblastoma multiforme and will secure access to disease cell-lines that best represent the tumor in patients. The funding received from Innovate UK is key to progress this highly innovative project and to accelerate the path to treatment for this deadly disease."
The company secured an £11m convertible loan to scale manufacturing and commercial operations for its point-of-care diagnostic system.
The financing round was led by BGF with participation from new and existing backers to support clinical development.
"We are thrilled to include this exceptional group of investors in PhoreMost’s Series B funding round. We are grateful for the continued support of existing investors and are delighted to welcome BGF, alongside strategic investors XtalPi with whom we have a highly valued ongoing research collaboration, and Astellas Venture Management."
